Latest Breaking News On - Crinetics pharmaceuticals - Page 1 : vimarsana.com

Frazier Life Sciences Management L.P. cut its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 75.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 397,483 shares of the company’s stock after selling 1,192,448 shares during the quarter. Frazier Life Sciences Management L.P.’s […]

Piper sandlerStephenf betzMarc wilsonNews ratings for crinetics pharmaceuticals dailyRafferty asset managementFrazier life sciences managementCrinetics pharmaceuticalsInsider transactions at crinetics pharmaceuticalsSecurities exchange commissionMorgan stanleyCrinetics pharmaceuticals trading downQuarter for crinetics pharmaceuticalsFirst light asset managementCrinetics pharmaceuticals incInvestment managementFree report